Sally Priester
Overview
Explore the profile of Sally Priester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang F, Priester S, Onori P, Venter J, Renzi A, Franchitto A, et al.
Am J Physiol Gastrointest Liver Physiol
. 2011 Sep;
301(6):G981-91.
PMID: 21903763
Increased cholangiocyte growth is critical for the maintenance of biliary mass during liver injury by bile duct ligation (BDL). Circulating levels of testosterone decline following castration and during cholestasis. Cholangiocytes...
2.
Priester S, Wise C, Glaser S
World J Gastrointest Pathophysiol
. 2011 May;
1(2):30-7.
PMID: 21607140
Cholangiocytes are the epithelial cells that line the biliary tree. In the adult liver, they are a mitotically dormant cell population, unless ductular reaction is triggered by injury. The ability...
3.
Meng F, Glaser S, Francis H, DeMorrow S, Han Y, Passarini J, et al.
J Cell Mol Med
. 2011 Mar;
16(1):160-73.
PMID: 21352471
MicroRNAs are endogenous small non-coding RNAs that regulate gene expression and cancer development. A rare population of hepatocellular cancer stem cells (HSCs) holds the extensive proliferative and self-renewal potential necessary...
4.
Miller T, Yang F, Wise C, Meng F, Priester S, Munshi M, et al.
Dig Liver Dis
. 2011 Feb;
43(5):395-403.
PMID: 21334995
Background: Simvastatin is a cholesterol-lowering drug that is widely used to prevent and treat atherosclerotic cardiovascular disease. Simvastatin exhibits numerous pleiotropic effects including anti-cancer activity. However, the effect of simvastatin...
5.
Munshi M, Priester S, Gaudio E, Yang F, Alpini G, Mancinelli R, et al.
Am J Pathol
. 2011 Feb;
178(2):472-84.
PMID: 21281779
The proliferation of cholangiocytes occurs during the progression of cholestatic liver diseases and is critical for the maintenance and/or restoration of biliary mass during bile duct damage. The ability of...